ZANPHOS
Dead / Abandoned — Abandoned — after publication (as of 14 Feb 2023)
What this means for you
This application is over — abandoned 13 Feb 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90047516
- Mark type
- Stylized text
- Filed
- 10 Jul 2020
- Published for opposition
- 24 Nov 2020
- Abandoned
- 13 Feb 2023
- Attorney of record
- Aaron D. Hendelman
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical products for the treatment of cancer and immune-related diseases and disorders; pharmaceuticals for use in the treatment of oncological disorders and diseases and immune-related diseases and disorders
Owner
- MEI Pharma Inc., San Diego, CA, US
- MEI Pharma Inc., San Diego, CA, US
Prosecution history
- 14 Feb 2023 — ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
- 14 Feb 2023 — ABANDONMENT - AFTER PUBLICATION
- 13 Feb 2023 — TEAS EXPRESS ABANDONMENT RECEIVED
- 19 Jul 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Jul 2022 — SOU EXTENSION 3 GRANTED
- 15 Jul 2022 — SOU EXTENSION 3 FILED
- 15 Jul 2022 — SOU TEAS EXTENSION RECEIVED
- 14 Jan 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Jan 2022 — SOU EXTENSION 2 GRANTED
- 12 Jan 2022 — SOU EXTENSION 2 FILED
- 12 Jan 2022 — SOU TEAS EXTENSION RECEIVED
- 15 Jul 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Jul 2021 — SOU EXTENSION 1 GRANTED
- 13 Jul 2021 — SOU EXTENSION 1 FILED
- 13 Jul 2021 — SOU TEAS EXTENSION RECEIVED